Joseph G. Pressey · Successful treatment of preadolescents with small cell carcinoma of the ovary hypercalcemic type
Follow
Article1 min read·Published Jan 2013Older

Successful treatment of preadolescents with small cell carcinoma of the ovary hypercalcemic type

pubmed.ncbi.nlm.nih.gov shows its articles on its own site.

Read the article on pubmed.ncbi.nlm.nih.gov ↗

Article · Jan 2013 · 1 min read

In brief

In brief

Two preadolescent patients with advanced-stage small cell carcinoma of the ovary hypercalcemic type achieved long-term remission through aggressive multimodal treatment combining cisplatin-based chemotherapy, surgical resection, and in one case high-dose chemotherapy with stem cell rescue, radiation, and bevacizumab maintenance. Both patients remain disease-free at 7 years and 30 months post-diagnosis.

Written by the GCMD Library team from the article.

Joseph G. Pressey

Background: Small cell carcinoma of the ovary hypercalcemic type (SCCOHT) is a rare tumor with a peak incidence in young adulthood that historically has carried a poor prognosis. Observations: We present 2 advanced stage cases of SCCOHT in preadolescents successfully treated with a combination of cisplatin-based chemotherapy and surgical resection. The more recent patient also underwent consolidative high-dose chemotherapy with stem cell rescue and external beam radiotherapy. Her therapy was concluded with a maintenance course of bevacizumab. The patients are now disease-free 7 years and 30 months, respectively, after diagnosis. Conclusions: With aggressive multimodal therapy SCCOHT is curable in children.

Statements in this article

  1. Small cell carcinoma of the ovary hypercalcemic type is a rare tumor with a peak incidence in young adulthood that historically has carried a poor prognosis.

    EstablishedBackground
  2. Two advanced stage cases of SCCOHT in preadolescents were successfully treated with a combination of cisplatin-based chemotherapy and surgical resection.

    ResearchObservations
  3. One patient underwent consolidative high-dose chemotherapy with stem cell rescue and external beam radiotherapy.

    ResearchObservations
  4. Therapy was concluded with a maintenance course of bevacizumab in one patient.

    ResearchObservations
  5. The patients are disease-free 7 years and 30 months, respectively, after diagnosis.

    ResearchObservations
  6. With aggressive multimodal therapy SCCOHT is curable in children.

    ResearchConclusions

Read it at the source ↗

Try
Intelligent Search· scoped to this article · not medical adviceSearch the whole library →
GCMD Library — educational content from recorded physician discussions, not medical advice.